Florida State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Florida State University sits in the top decile of US sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count).
Florida State University: 219 sponsored US clinical trials, 47 recruiting.
Florida State University sponsors 219 registered US clinical trials on ClinicalTrials.gov, 47 of them currently recruiting, and 156 completed. 1 of these trials are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 6 trials.
Top-decile sponsor footprint
Florida State University ranks in the top decile of sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 162 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
219 total, page 5 of 5
The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke
NCT01841840
Blueberry Consumption Improves Vascular Function and Lowers Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension
NCT01686282
Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy
NCT01505101
Music Therapy as Procedural Support for Young Children Undergoing Immunizations
NCT01463176
Cognitive Anxiety Sensitivity Treatment for Suicide
NCT01947179
Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function
NCT01741779
Nighttime Macronutrient Choice and Combined Resistance and High-intensity Interval Training
NCT01830946
Identifying Adverse Events After Discharge From a Community Hospital
NCT01536340
The Effects of Stretching Training on Arterial Function and Autonomic Control
NCT01741766
L-citrulline Supplementation & Cold Exposure
NCT01462591
Low-intensity Resistance Exercise and Diet on Arterial Function and Blood Pressure
NCT01371370
Watermelon Supplementation and Arterial Stiffness
NCT01185041
Impact of Group Size in Weight Loss Interventions
NCT01165151
False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders
NCT02082561
Depression Management at the Workplace
NCT01013220
Smoking Treatment and Anxiety Management Program
NCT01753141
Comparing Parent-Implemented Interventions for Toddlers With Autism Spectrum Disorders
NCT00760812
Promoting Physical Activity Among Patients With Type 2 Diabetes
NCT00547027
Interactive Computer Treatment for Panic Disorder
NCT00063375
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 6 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Florida State University pipeline
47 recruiting of 219 indexed (21% open); 156 completed (71%).
Phase mix: 1 late (III/IV) vs 13 early (I/II) (early-phase heavy).
Top condition: Chronic Pain (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Florida State University: open-pipeline peers nationwide
Peers matched on 219 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Florida State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 219 trials (± recruiting share)
- Penn State University · 219 trials · 17% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
- University of Louisville · 217 trials · 21% recruiting
Sponsors near 21% open enrollment (± trial volume)
- AbbVie · 21% recruiting · 526 trials
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
Related
What to do with this Florida State University page
219 registered trials is a research-attention snapshot, not an endorsement of Florida State University or any single study.
- 47 of Florida State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition Florida State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Florida State University pipeline card: 219 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.